| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |